• 1. Enantiomorphic symmetry breaking in crystallization of molten sodium chlorate?
  Martin R. Ward,Gary W. Copeland,Andrew J. Alexander Chem. Commun., 2010,46, 7634-7636
• 2. Etching of glass microchips with supercritical water?
  Pavel Karásek,Jakub Grym,Michal Roth,Josef Planeta,Franti?ek Foret Lab Chip, 2015,15, 311-318
• 3. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 4. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 5. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459

Research Brief on 5-Chloro-2,4-dimethylpyrimidine (CAS: 75712-73-1): Recent Advances and Applications in Chemical Biology and Medicine

5-Chloro-2,4-dimethylpyrimidine (CAS: 75712-73-1) is a key heterocyclic compound that has garnered significant attention in the fields of chemical biology and medicinal chemistry due to its versatile applications in drug discovery and development. Recent studies have highlighted its role as a crucial intermediate in the synthesis of bioactive molecules, particularly in the design of kinase inhibitors and antimicrobial agents. This research brief consolidates the latest findings on the compound, focusing on its synthetic utility, mechanistic insights, and therapeutic potential.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the efficacy of 5-Chloro-2,4-dimethylpyrimidine as a scaffold for developing selective kinase inhibitors targeting aberrant signaling pathways in cancer. Researchers utilized structure-activity relationship (SAR) analysis to optimize the compound's binding affinity, resulting in derivatives with nanomolar potency against specific oncogenic kinases. The study also emphasized the compound's favorable pharmacokinetic properties, such as metabolic stability and oral bioavailability, which are critical for clinical translation.

In addition to its oncological applications, 5-Chloro-2,4-dimethylpyrimidine has shown promise in antimicrobial research. A recent ACS Infectious Diseases article (2024) reported its incorporation into novel broad-spectrum antibiotics targeting multidrug-resistant Gram-negative bacteria. The compound's chloro and methyl substituents were found to enhance membrane permeability and disrupt bacterial efflux pumps, addressing a major challenge in antibiotic development. Computational modeling further validated its interactions with key bacterial enzymes, providing a roadmap for future analog design.

From a synthetic chemistry perspective, advancements in green chemistry protocols have improved the scalability of 5-Chloro-2,4-dimethylpyrimidine production. A 2024 Organic Process Research & Development paper detailed a solvent-free mechanochemical synthesis route that achieved >90% yield while minimizing hazardous waste. This methodological innovation aligns with the pharmaceutical industry's growing emphasis on sustainable manufacturing practices.

Ongoing clinical trials (Phase I/II) are investigating 5-Chloro-2,4-dimethylpyrimidine-derived compounds for neurodegenerative diseases, leveraging its ability to cross the blood-brain barrier. Preliminary data suggest neuroprotective effects through modulation of protein aggregation pathways. However, researchers caution that further toxicological studies are needed to fully assess its safety profile in chronic administration scenarios.

In conclusion, 5-Chloro-2,4-dimethylpyrimidine continues to emerge as a multifaceted building block in medicinal chemistry, with recent breakthroughs expanding its applications across therapeutic areas. Future research directions include exploring its potential in immunotherapy and developing more efficient catalytic systems for its asymmetric functionalization. The compound's unique chemical properties and demonstrated bioactivity ensure its enduring relevance in pharmaceutical innovation.

• 114969-79-8(5-Chloro-4-methylpyrimidine-2-carbonitrile)
• 75712-75-3(5-Chloro-4,6-dimethylpyrimidine)
• 857428-36-5(5-Chloro-2-methyl-4-pyrimidinecarbonitrile)
• 54198-82-2(5-chloro-4-methylpyrimidine)
• 24307-72-0(5-Chloro-2,4,6-trimethylpyrimidine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)